Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses
General and administrative	$ 1,235,661	$ 2,080,644	$ 4,467,065	$ 8,273,344
Research and development	762,717	1,281,455	1,736,373	5,531,436
Depreciation and amortization	84,814	86,296	255,002	259,300
Total operating expenses	2,083,192	3,448,395	6,458,440	14,064,080
Loss from operations	(2,083,192)	(3,448,395)	(6,458,440)	(14,064,080)
Other income (expense)
Change in fair value of warrant liabilities	(122)	67,822	20,722	(115,342)
Change in fair value of investment option liability	(501)	562,715	18,664	(399,921)
Change in fair value of derivative liability				727,000
Interest income (expense), net	(217)	2,237	444	3,142
Total other income (expense)	(840)	632,774	39,830	214,879
Net loss before income taxes	(2,084,032)	(2,815,621)	(6,418,610)	(13,849,201)
Income tax expense		(6,595)	(1,731)	(6,595)
Net loss	(2,084,032)	(2,822,216)	(6,420,341)	(13,855,796)
Less preferred dividends attributable to non-controlling interest				19,041
Less deemed dividends attributable to accretion of embedded derivative at redemption value				147,988
Net loss attributable to shareholders	(2,084,032)	(2,822,216)	(6,420,341)	(14,022,825)
Other comprehensive income
Foreign currency translation	31,497	10,433	34,751	1,115
Comprehensive loss	$ (2,052,535)	$ (2,811,783)	$ (6,385,590)	$ (14,021,710)
Net loss per share - basic	$ (0.24)	$ (1.30)	$ (0.95)	$ (6.62)
Net loss per share - diluted	$ (0.24)	$ (1.30)	$ (0.95)	$ (6.62)
Weighted average shares outstanding, basic	8,702,951	2,164,656	6,771,162	2,117,153
Weighted average shares outstanding, diluted	8,702,951	2,164,656	6,771,162	2,117,153